Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in Ankylosing Spondylitis
NCT00000433Phase 2Completed
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Start
- Oct 1999
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of etanercept in ankylosing spondylitis (AS), sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases. Started Oct 1999; status: completed.
02
Drugs
etanercept
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT00000433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000433.